Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fetzima (levomilnacipran hydrochloride) from Allergan, Inc., representing a regulatory action related to this antide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FETZIMA (levomilnacipran hydrochloride)

Snippet

SUPPL AP for FETZIMA (LEVOMILNACIPRAN HYDROCHLORIDE)